All Africa picked up GHTC's press release on the launch of Return on innovation: Why global health R&D is a smart investment for the United States, covering the economic impact of US government investment in health R&D.
New Scientist interviewed GHTC Director Jamie Bay Nishi about the coalition's report Return on innovation: Why global health R&D is a smart investment for the United States, which highlights the jobs and economic impact US investment in global health R&D has had on the United States.
NPR Goats & Soda explored in-depth the findings from GHTC's new report, Return on innovation: Why global health R&D is a smart investment for United States, which analyzes the health and economic impact of US government spending on global health R&D.
Wired explored the impact budget cuts to global health R&D could have on US health security and the American economy, citing findings from GHTC's report Return on innovation: Why global health R&D is a smart investment for the United States.